• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Advisory Councils/Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Archives
      • Newsletters
      • Meetings
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

“Day in the Life Of” Suite

One of the Most Powerful Experiences at the Allied Professionals Forum

What does daily life with ALS/MND truly look like, and how can care, technology, and innovation make it better?

The “Day in the Life Of” (DILO) Suite is a signature immersive experience at the Allied Professionals Forum that brings these questions to life in a practical, human way. Designed for healthcare professionals, allied specialists, researchers, people living with ALS/MND, caregivers, and industry partners, it recreates key moments in a typical day and showcases solutions that can support independence, communication, comfort, mobility, and quality of life.

Step Inside Real-World Solutions

As attendees move through the Suite, they experience a hands-on journey through the daily realities of living with ALS/MND and explore tools that can make a meaningful difference at every stage.

Featured technologies and solutions have included:

  • Eye gaze communication systems
  • Voice cloning technologies
  • Mechanical eating aids
  • Smart-home accessibility tools
  • Adaptive travel equipment
  • Mobility and positioning supports
  • Nutrition and swallowing solutions
  • Practical tools for caregivers

Throughout the experience, specialists are available for live demonstrations, practical guidance, and one-to-one conversations.

Participants consistently value the DILO Suite because it offers something rare: the chance to connect clinical knowledge with everyday life. They leave with practical ideas they can apply immediately, new approaches to patient-centred care, and firsthand experience with emerging technologies.

For many attendees, the DILO Suite has become one of the most memorable parts of the Allied Professionals Forum, offering a type of learning that traditional sessions cannot.

Whether you work in clinical care, research, advocacy, caregiving, or product development, the experience provides insights that stay with you long after the conference ends.

Watch the 2025 Walk-Through

Take a tour of the 2025 DILO Suite in the video below.

 

Primary Sidebar

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Alberto Baez Murillo, Colombia

    Alberto Baez Murillo, Colombia

  • Mauril Bélanger, Canada

    Mauril Bélanger, Canada

  • Liam Dwyer, England

    Liam Dwyer, England

  • Mauricio Dorin, Argentina

    Mauricio Dorin, Argentina

  • Jo Knowlton, Scotland

    Jo Knowlton, Scotland

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Motoko Ogasawara, Japan

    Motoko Ogasawara, Japan

  • Armando González Gómez, Colombia

    Armando González Gómez, Colombia

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Emilienne Verhaegen, Belgium

    Emilienne Verhaegen, Belgium

  • Ywan Dierick, Belgium

    Ywan Dierick, Belgium

  • Valdomiro Xavier Honório, Brazil

    Valdomiro Xavier Honório, Brazil

  • Josée Kolijn-de Man, Netherlands

    Josée Kolijn-de Man, Netherlands

  • Robbie Caliste, UK

    Robbie Caliste, UK

  • Enzo Maccarrone, Italy

    Enzo Maccarrone, Italy

  • Dawn Morton, Scotland

    Dawn Morton, Scotland

  • Barry de Reuver, Netherlands

    Barry de Reuver, Netherlands

  • Bayley, Australia

    Bayley, Australia

  • Jean

    Jean
    jean

  • Maria Lucia Wood Saldanha, Brazil

    Maria Lucia Wood Saldanha, Brazil

  • Rob Tison, USA

    Rob Tison, USA

  • Andrietta, Italy

    Andrietta, Italy
    Andrietta

  • Dick Dayton, USA

    Dick Dayton, USA

  • Charlie Dourney, USA

    Charlie Dourney, USA

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

  • Yessenia Hernandez Mendoza, Mexico

    Yessenia Hernandez Mendoza, Mexico

  • Liz Ogg, Scotland

    Liz Ogg, Scotland

  • Jorge Melo, Brazil

    Jorge Melo, Brazil

  • Federica Mastrosimone, Italy

    Federica Mastrosimone, Italy

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Horacio Fritzer, Argentina

    Horacio Fritzer, Argentina

  • Willi Klein, UK

    Willi Klein, UK

  • Feng Gin Sun, China

    Feng Gin Sun, China

  • Hollister

    Hollister
    hollister

  • Jack Buzby, USA

    Jack Buzby, USA

  • Eddy Lefrancois, Canada

    Eddy Lefrancois, Canada

  • Sharon Corosanite, USA

    Sharon Corosanite, USA

  • John Dinon, Australia

    John Dinon, Australia

  • Jan Zuring, Netherlands

    Jan Zuring, Netherlands

  • Angie Bordaen, Belgium

    Angie Bordaen, Belgium

  • Carlos Alberto Arango, Colombia

    Carlos Alberto Arango, Colombia

  • Oscar Mauricio Linares, Colombia

    Oscar Mauricio Linares, Colombia

  • Steve

    Steve

  • Jon Newsome, USA

    Jon Newsome, USA

  • Ali Var, Turkey

    Ali Var, Turkey

  • Debbie Craghill, USA

    Debbie Craghill, USA

  • Wendy Hendrickson, USA

    Wendy Hendrickson, USA

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login